JPH04230620A - Bathing agent - Google Patents
Bathing agentInfo
- Publication number
- JPH04230620A JPH04230620A JP41879990A JP41879990A JPH04230620A JP H04230620 A JPH04230620 A JP H04230620A JP 41879990 A JP41879990 A JP 41879990A JP 41879990 A JP41879990 A JP 41879990A JP H04230620 A JPH04230620 A JP H04230620A
- Authority
- JP
- Japan
- Prior art keywords
- calcium chloride
- bath
- magnesium chloride
- bathing
- chloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000003287 bathing Methods 0.000 title claims abstract description 18
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims abstract description 40
- 239000001110 calcium chloride Substances 0.000 claims abstract description 27
- 229910001628 calcium chloride Inorganic materials 0.000 claims abstract description 27
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims abstract description 26
- 229910001629 magnesium chloride Inorganic materials 0.000 claims abstract description 20
- 150000004683 dihydrates Chemical class 0.000 claims abstract description 6
- 150000004687 hexahydrates Chemical class 0.000 claims abstract description 5
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 3
- 230000000694 effects Effects 0.000 abstract description 14
- 208000017520 skin disease Diseases 0.000 abstract description 6
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 abstract description 2
- 239000000654 additive Substances 0.000 description 11
- 230000000996 additive effect Effects 0.000 description 9
- 208000010668 atopic eczema Diseases 0.000 description 5
- 235000019341 magnesium sulphate Nutrition 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 208000010201 Exanthema Diseases 0.000 description 3
- 208000007882 Gastritis Diseases 0.000 description 3
- 206010027627 Miliaria Diseases 0.000 description 3
- 208000000112 Myalgia Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 201000005884 exanthem Diseases 0.000 description 3
- 208000014617 hemorrhoid Diseases 0.000 description 3
- DHRRIBDTHFBPNG-UHFFFAOYSA-L magnesium dichloride hexahydrate Chemical compound O.O.O.O.O.O.[Mg+2].[Cl-].[Cl-] DHRRIBDTHFBPNG-UHFFFAOYSA-L 0.000 description 3
- 208000013465 muscle pain Diseases 0.000 description 3
- 230000001272 neurogenic effect Effects 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- LLSDKQJKOVVTOJ-UHFFFAOYSA-L calcium chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Ca+2] LLSDKQJKOVVTOJ-UHFFFAOYSA-L 0.000 description 2
- -1 dihydrate salt Chemical class 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 2
- 201000004647 tinea pedis Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- 206010008528 Chillblains Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 208000019872 Drug Eruptions Diseases 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- QHFQAJHNDKBRBO-UHFFFAOYSA-L calcium chloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2] QHFQAJHNDKBRBO-UHFFFAOYSA-L 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Abstract
Description
【０００１】0001
【産業上の利用分野】本発明は、入浴剤に関するもので
ある。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to bath additives.
【０００２】0002
【従来の技術】塩化カルシウムは、じんましん、湿疹、
薬疹、アレルギー性掻痒症等の皮膚疾患を始めとする疾
患の治療に有効であることは知られている。しかし塩化
カルシウムは従来、注射又は経口投与の方法で患者に適
用されており、入浴剤の形態で適用することは全く行わ
れていなかった。[Prior art] Calcium chloride can cause hives, eczema,
It is known to be effective in treating diseases including skin diseases such as drug eruptions and allergic pruritus. However, calcium chloride has conventionally been applied to patients by injection or oral administration, and has never been applied in the form of bath additives.
【０００３】0003
【発明が解決しようとする課題】本発明者は塩化カルシ
ウムを入浴剤として用いるという新しい着想のもとに種
々の研究を重ねてきた。しかし塩化カルシウムを単独で
入浴剤として用いると若干の温浴効果はあるが、不十分
であり、期待した入浴効果を得ることはできなかった。[Problems to be Solved by the Invention] The present inventor has conducted various studies based on the new idea of using calcium chloride as a bath additive. However, when calcium chloride is used alone as a bathing agent, although it has a slight warming bathing effect, it is insufficient, and the expected bathing effect cannot be obtained.
【０００４】本発明は塩化カルシウムを入浴剤の有効成
分として使用し、顕著な入浴効果を発現せしめ得る人浴
剤を提供するものである。[0004] The present invention uses calcium chloride as an active ingredient of the bath additive, and provides a bath additive that can exhibit remarkable bathing effects.
【０００５】[0005]
【課題を解決するための手段】本発明は、塩化カルシウ
ム及び塩化マグネシウムを、前者の２水塩換算重量１に
対し後者を６水塩換算重量として０．１−０．３の割合
で含有することを特徴とする入浴剤に係るものである。[Means for Solving the Problems] The present invention contains calcium chloride and magnesium chloride in a ratio of 0.1 to 0.3, expressed as a hexahydrate weight, of the latter to 1 weight of the former in terms of dihydrate. The present invention relates to a bath additive characterized by the following.
【０００６】本発明者の研究によれば、塩化カルシウム
を塩化マグネシウムと組み合わせて入浴剤とし、浴槽に
投入すると、入浴時にぽかぽかとした皮膚刺激を感じ、
入浴後も長時間ぬくもりが持続し、かつ、両成分の浸透
圧作用により入浴による発汗が強く起こり毛穴が開き皮
膚の汚れを落とし易くする等の温浴効果が顕著に発現さ
れ、しかも吸収された塩化カルシウム及び塩化マグネシ
ウムはそれぞれの薬効を発現することを見出した。即ち
塩化カルシウムは皮膚をすべすべと滑らかにし湿疹、か
ぶれ、水虫、あせも等の皮膚疾患に効果を発現して、疾
患を軽減乃至治癒せしめ、また、塩化マグネシウムは便
通を促進する。更に塩化カルシウムの末梢神経刺激作用
や温浴効果が作用して種々の入浴効果が得られる。実際
に本発明者が複数のパネラーに依頼して行った入浴試験
ではぽかぽかとしたぬくもりの持続等の温浴効果はもと
より、疲れがとれ、身体が柔らかくなり、皮膚病が治癒
し、腰痛、筋肉痛、肩こり、痔、神経性胃炎の痛みがと
れ、便秘症状が軽減され、利尿作用もある等の効果が得
られている。本発明によって係る顕著な効果が得られる
理由は明らかではないが、塩化カルシウムと塩化マグネ
シウムとを組み合わせて用いることにより、塩化カルシ
ウム及び塩化マグネシウムの皮膚吸収性が高められるこ
とによるものと予測される。[0006] According to the research of the present inventor, when calcium chloride is combined with magnesium chloride to make a bath additive and is added to the bathtub, the skin feels warm and irritated when taking a bath.
The warmth lasts for a long time even after bathing, and the osmotic pressure effect of both ingredients causes strong sweating during bathing, which opens pores and makes it easier to remove dirt from the skin. It has been found that calcium and magnesium chloride exhibit their respective medicinal effects. That is, calcium chloride makes the skin smooth and has an effect on skin diseases such as eczema, rash, athlete's foot, and heat rash, thereby alleviating or curing the disease, and magnesium chloride promotes bowel movements. Furthermore, various bathing effects can be obtained due to the peripheral nerve stimulating effect and warm bathing effect of calcium chloride. In fact, bathing tests conducted by the present inventor with multiple panelists showed that not only did the hot bath have a lasting effect of warmth, but it also relieved fatigue, made the body soft, cured skin diseases, and reduced back pain and muscle pain. It has been shown to relieve pain from stiff shoulders, hemorrhoids, and neurogenic gastritis, reduce symptoms of constipation, and has a diuretic effect. Although the reason why such remarkable effects are obtained by the present invention is not clear, it is predicted that the use of calcium chloride and magnesium chloride in combination increases the skin absorption of calcium chloride and magnesium chloride.
【０００７】本発明において塩化カルシウム及び塩化マ
グネシウムはいずれも無水塩乃至種々の含水塩の形態で
使用可能であるが、特に塩化カルシウムは２水塩の形態
でまた塩化マグネシウムは６水塩の形態で使用するのが
好ましい。また、本発明においては、塩化カルシウムに
対し塩化マグネシウムを前者１（２水塩換算）に対し後
者０．１−０．３（６水塩換算）の割合で用いることを
不可欠とし、これによってのみ上記の顕著な効果が得ら
れる。塩化マグネシウム（６水塩）の量が０．１未満で
は温浴効果が不足し塩化カルシウムの吸収性も低下する
。一方この量が０．３を越えると入浴効果が落ちる。
好ましい割合は塩化カルシウム（２水塩）１に対して塩
化マグネシウム（６水塩）０．１５−０．２５近傍であ
り、かかる使用割合において最も入浴効果が顕著となる
。[0007] In the present invention, both calcium chloride and magnesium chloride can be used in the form of an anhydrous salt or various hydrated salts, but especially calcium chloride can be used in the form of a dihydrate salt, and magnesium chloride can be used in the form of a hexahydrate salt. It is preferable to use In addition, in the present invention, it is essential to use magnesium chloride to calcium chloride in a ratio of 1 (dihydrate equivalent) to the latter 0.1-0.3 (hexahydrate equivalent), and only by this. The above remarkable effects can be obtained. If the amount of magnesium chloride (hexahydrate) is less than 0.1, the hot bath effect will be insufficient and the absorption of calcium chloride will also decrease. On the other hand, if this amount exceeds 0.3, the bathing effect will decrease. A preferred ratio is around 0.15 to 0.25 of magnesium chloride (hexahydrate) to 1 part of calcium chloride (dihydrate), and the bathing effect is most pronounced at this usage ratio.
【０００８】本発明入浴剤は、粉末剤、顆粒剤、錠剤、
発泡錠剤、液剤等の公知の各種形態とすることができる
。製剤にあたっては、必要に応じて塩化カルシウム及び
塩化マグネシウムを賦形剤、着色剤、香料、その他、公
知の各種補助剤とともに公知方法に従い製剤すればよい
。また本発明入浴剤には塩化カルシウム及び塩化マグネ
シウムの他に必要に応じて公知の各種入浴剤成分を配合
することもできる。[0008] The bath additive of the present invention can be used as a powder, granule, tablet,
It can be made into various known forms such as effervescent tablets and liquid preparations. For formulation, calcium chloride and magnesium chloride may be formulated according to known methods together with excipients, coloring agents, fragrances, and various other known auxiliary agents, if necessary. In addition to calcium chloride and magnesium chloride, the bath additive of the present invention may also contain various known bath additive components as required.
【０００９】粒剤を製造するにあたって、塩化カルシウ
ムと塩化マグネシウムを単に混合しても、大きさや比重
に差があり、成分の均一性を保持できない。従って例え
ば、塩化カルシウム（２水塩）を、塩化マグネシウム（
６水塩）の溶融する温度である９０℃以上に加熱攪拌し
、塩化カルシウムの水分を除去し、成分を高めながら塩
化マグネシウムを加え攪拌を続け、塩化マグネシウム（
６水塩）を溶融させ、塩化カルシウム（２水塩）と結合
させる。この時の加熱は、１１０℃までとし、溶融した
塩化マグネシウムの分解を防ぐ。これを冷却すると塩化
カルシウムと塩化マグネシウムとが均一に結合した粒剤
を得ることができる。本発明入浴剤を使用するにあたっ
ては、その使用量は入浴効果が得られる限り特に制限は
なく、広い範囲に亘り得るが、特に好ましいのは、有効
成分（塩化カルシウム及び塩化マグネシウム）量として
０．１−１．０ｇ／リットル浴の割合である。[0009] When producing granules, even if calcium chloride and magnesium chloride are simply mixed, there are differences in size and specific gravity, and uniformity of the components cannot be maintained. Therefore, for example, calcium chloride (dihydrate) can be replaced with magnesium chloride (
Heating and stirring above 90°C, which is the temperature at which calcium chloride (hexahydrate) melts, removes moisture from calcium chloride, adds magnesium chloride while increasing the composition, and continues stirring.
Hexahydrate) is melted and combined with calcium chloride (dihydrate). The heating at this time is limited to 110° C. to prevent decomposition of the molten magnesium chloride. When this is cooled, granules in which calcium chloride and magnesium chloride are uniformly combined can be obtained. When using the bath additive of the present invention, there is no particular restriction on the amount used as long as the bathing effect is obtained, and it can be used within a wide range, but it is particularly preferable that the amount of active ingredients (calcium chloride and magnesium chloride) be 0. The ratio is 1-1.0 g/liter bath.
【００１０】0010
【実施例】重量比で塩化カルシウム（２水塩）１に対し
て塩化マグネシウム（６水塩）０．２を加熱攪拌し溶融
し、結合させ冷却して、直径２−５ｍｍの粒剤を得た。
この入浴剤の成分分析をしたところ、カルシウムイオン
２２２．８ｍｇ／ｇ、マグネシウムイオン３６．６ｍｇ
／ｇ、ナトリウムイオン４．６ｍｇ／ｇ、カリウムイオ
ン２．６ｍｇ／ｇ、硫酸イオン０．３ｍｇ／ｇ、塩素イ
オン４６８．８ｍｇ／ｇ、結晶水２６４．３ｍｇ／ｇで
あった。[Example] A weight ratio of 0.2 of magnesium chloride (hexahydrate) to 1 of calcium chloride (dihydrate) was heated, stirred, melted, combined, and cooled to obtain granules with a diameter of 2-5 mm. Ta. When we analyzed the ingredients of this bath salt, we found that it contained 222.8 mg/g of calcium ions and 36.6 mg/g of magnesium ions.
/g, sodium ion 4.6 mg/g, potassium ion 2.6 mg/g, sulfate ion 0.3 mg/g, chlorine ion 468.8 mg/g, and crystal water 264.3 mg/g.
【００１１】各家庭の風呂（１５０リットル−２００リ
ットル）に本入浴剤３０ｇを１回の使用量として、男６
名女９名計１５名の成人により継続使用試験を行った。
入浴剤を入れない浴湯に比較して、入浴時にぽかぽかと
した皮膚刺激を感じた者は９名、入浴後、ぬくもりが３
０分以上持続した者は１２名、皮膚が荒れた者はなく、
すべすべになった者は７名、水虫・あせも・湿疹・かぶ
れ等の皮膚病が治った者は８名、腰痛・筋肉痛・肩こり
・痔・神経性胃炎等の痛みがとれた者は６名、疲れがと
れたり・身体が柔らかくなった者は１１名であった。１
５名中効用を認めなかった者は３名であり、１２名はな
んらかの効用をみとめた。[0011] Each household bath (150 liters to 200 liters) uses 30 g of this bath salt at a time, and 6 men
A continuous use test was conducted with a total of 15 adults, including 9 famous women. Compared to bathing without bath salts, 9 people felt warm skin irritation when taking a bath, and 3 people felt warm after bathing.
There were 12 people whose skin lasted for more than 0 minutes, and no one had rough skin.
Seven people became smoother, eight people recovered from skin diseases such as athlete's foot, heat rash, eczema, and rashes, and six people recovered from pain such as lower back pain, muscle pain, stiff shoulders, hemorrhoids, and neurogenic gastritis. There were 11 people who felt relieved of fatigue or felt more flexible. 1
Of the 5 participants, 3 did not find any benefit, and 12 found some benefit.
【００１２】0012
【効果】本入浴剤は、入浴時ぽかぽかとした皮膚刺激を
感じ、入浴後長時間に亘ってぬくもりが持続し、入浴に
よる発汗が強くおこり毛穴が開き皮膚の汚れも落としや
すくすると共に、水虫・あせも・湿疹・かぶれ・しもや
け等の皮膚病、肩こり・筋肉痛・腰痛・便秘・痔・神経
性胃炎等の痛みに薬効を発現する。また身体が柔らかく
なり、疲れを取り、利尿作用もある。[Effects] This bath salt will make your skin feel warm and irritated when you take a bath, and the warmth will last for a long time after taking a bath.The bath salt will cause you to sweat strongly, opening your pores and making it easier to remove dirt from your skin. It has medicinal effects on skin diseases such as heat rash, eczema, rash, and chilblains, and pain such as stiff shoulders, muscle pain, lower back pain, constipation, hemorrhoids, and neurogenic gastritis. It also softens the body, relieves fatigue, and has a diuretic effect.
Claims (1)
前者の２水塩換算重量１に対し後者を６水塩換算重量と
して０．１−０．３の割合で含有することを特徴とする
入浴剤。Claim 1: Calcium chloride and magnesium chloride,
A bathing agent characterized in that the latter is contained in a ratio of 0.1 to 0.3 in terms of hexahydrate weight per 1 weight of the former in terms of dihydrate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2418799A JPH0735326B2 (en) | 1990-12-28 | 1990-12-28 | Bath additive |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2418799A JPH0735326B2 (en) | 1990-12-28 | 1990-12-28 | Bath additive |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH04230620A true JPH04230620A (en) | 1992-08-19 |
| JPH0735326B2 JPH0735326B2 (en) | 1995-04-19 |
Family
ID=18526580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2418799A Expired - Lifetime JPH0735326B2 (en) | 1990-12-28 | 1990-12-28 | Bath additive |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0735326B2 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0716851A1 (en) * | 1994-12-15 | 1996-06-19 | WOGEPHARM GmbH | Bath salt containing a magnesium salt and its manufacture process |
| EP0801570A4 (en) * | 1994-12-21 | 1998-12-30 | Cosmederm Technologies | Formulations and methods for reducing skin irritation |
-
1990
- 1990-12-28 JP JP2418799A patent/JPH0735326B2/en not_active Expired - Lifetime
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0716851A1 (en) * | 1994-12-15 | 1996-06-19 | WOGEPHARM GmbH | Bath salt containing a magnesium salt and its manufacture process |
| EP0801570A4 (en) * | 1994-12-21 | 1998-12-30 | Cosmederm Technologies | Formulations and methods for reducing skin irritation |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0735326B2 (en) | 1995-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5958462A (en) | Therapeutic bath salts and method of use | |
| CN106109932A (en) | A kind of whitening and speckle dispelling Chinese medicine composition, whitening and speckle dispelling Chinese medicine preparation, whitening and speckle dispelling facial cream, preparation method | |
| CN105311060A (en) | Traditional Chinese medicine composition for treating oral ulcer and preparation method of traditional Chinese medicine composition | |
| US20060172022A1 (en) | Skin treating salve composition | |
| JPH04230620A (en) | Bathing agent | |
| CN105832630A (en) | Manufacturing method of rinsing-free pearl powder face mask without rinsing | |
| US5443834A (en) | Soap compounded with vitamin B1 -containing garlic extract | |
| JP2001064187A (en) | Skin agent for external use | |
| JPH1025240A (en) | Bathing agent | |
| JPS62181219A (en) | Remedy for decubitus | |
| JP3980843B2 (en) | Foot bath composition | |
| CN105878158A (en) | Tearing pearl powder mask | |
| JP3534470B2 (en) | Method for producing bath or massage agent | |
| CN103272017B (en) | Drug for treating burns and scalds | |
| Juarez | Hydrotherapy Manual | |
| CN1067374A (en) | Hot spring powder and application | |
| JP2010024184A (en) | Swelling-ameliorating composition and method for ameliorating swelling by utilizing the same | |
| CA1197192A (en) | Burn treatment composition | |
| JPH05194245A (en) | Massaging agent | |
| CN105878157A (en) | Wash-free pearl powder mask | |
| CN1048893C (en) | Zengshengling oil and preparing method thereof | |
| US20050123651A1 (en) | Mineral water composition | |
| CN1090933C (en) | Spot-removing beautifying face cream | |
| CN1314153A (en) | Mineral salt composition and its use | |
| JPH07277947A (en) | Bathing agent |